ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Allergic Asthma Therapeutics Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-19V14007
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Allergic Asthma Therapeutics Market Insights Forecast to 2029
BUY CHAPTERS

Global Allergic Asthma Therapeutics Market Research Report 2025

Code: QYRE-Auto-19V14007
Report
January 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Axikin Pharmaceuticals, Inc.
Baxalta Incorporated
Chiesi Farmaceutici SpA
Circassia Pharmaceuticals Plc
CSL Limited
Fountain Biopharma Inc
GlaxoSmithKline PLC
Hydra Biosciences Inc
Infinity Pharmaceuticals, Inc.
Kineta
Mabtech
Marinomed Biotechnologie GmbH
Mycenax Biotech Inc
Neopharm
Oxagen Limited
Panacea Biotec Limited
Aslan Pharmaceuticals Pte Ltd

Allergic Asthma Therapeutics Market Size

The global market for Allergic Asthma Therapeutics was valued at US$ 6865 million in the year 2024 and is projected to reach a revised size of US$ 8295 million by 2031, growing at a CAGR of 2.8% during the forecast period.

Allergic Asthma Therapeutics Market

Allergic Asthma Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Allergic Asthma Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergic Asthma Therapeutics.
The Allergic Asthma Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Allergic Asthma Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergic Asthma Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Allergic Asthma Therapeutics Market Report

Report Metric Details
Report Name Allergic Asthma Therapeutics Market
Accounted market size in year US$ 6865 million
Forecasted market size in 2031 US$ 8295 million
CAGR 2.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • ASM-8
  • AXP-1275
  • Beta-escin
  • CHF-6001
  • CSL-311
  • Dalazatide
  • Others
Segment by Application
  • Clinic
  • Research Center
  • Hospital
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Aslan Pharmaceuticals Pte. Ltd., Axikin Pharmaceuticals, Inc., Baxalta Incorporated, Chiesi Farmaceutici SpA, Circassia Pharmaceuticals Plc, CSL Limited, Fountain Biopharma Inc., GlaxoSmithKline Plc, Hydra Biosciences, Inc., Infinity Pharmaceuticals, Inc., Kineta, Inc., Mabtech Limited, Marinomed Biotechnologie GmbH, Mycenax Biotech Inc., NeoPharm Co., Ltd., Oxagen Limited, Panacea Biotec Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Allergic Asthma Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Allergic Asthma Therapeutics Market growing?

Ans: The Allergic Asthma Therapeutics Market witnessing a CAGR of 2.8% during the forecast period 2025-2031.

What is the Allergic Asthma Therapeutics Market size in 2031?

Ans: The Allergic Asthma Therapeutics Market size in 2031 will be US$ 8295 million.

Who are the main players in the Allergic Asthma Therapeutics Market report?

Ans: The main players in the Allergic Asthma Therapeutics Market are Aslan Pharmaceuticals Pte. Ltd., Axikin Pharmaceuticals, Inc., Baxalta Incorporated, Chiesi Farmaceutici SpA, Circassia Pharmaceuticals Plc, CSL Limited, Fountain Biopharma Inc., GlaxoSmithKline Plc, Hydra Biosciences, Inc., Infinity Pharmaceuticals, Inc., Kineta, Inc., Mabtech Limited, Marinomed Biotechnologie GmbH, Mycenax Biotech Inc., NeoPharm Co., Ltd., Oxagen Limited, Panacea Biotec Limited

What are the Application segmentation covered in the Allergic Asthma Therapeutics Market report?

Ans: The Applications covered in the Allergic Asthma Therapeutics Market report are Clinic, Research Center, Hospital, Others

What are the Type segmentation covered in the Allergic Asthma Therapeutics Market report?

Ans: The Types covered in the Allergic Asthma Therapeutics Market report are ASM-8, AXP-1275, Beta-escin, CHF-6001, CSL-311, Dalazatide, Others

Recommended Reports

Allergy Therapeutics

Asthma Medication

Allergic Rhinitis Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allergic Asthma Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ASM-8
1.2.3 AXP-1275
1.2.4 Beta-escin
1.2.5 CHF-6001
1.2.6 CSL-311
1.2.7 Dalazatide
1.2.8 Others
1.3 Market by Application
1.3.1 Global Allergic Asthma Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Research Center
1.3.4 Hospital
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Allergic Asthma Therapeutics Market Perspective (2020-2031)
2.2 Global Allergic Asthma Therapeutics Growth Trends by Region
2.2.1 Global Allergic Asthma Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Allergic Asthma Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Allergic Asthma Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Allergic Asthma Therapeutics Market Dynamics
2.3.1 Allergic Asthma Therapeutics Industry Trends
2.3.2 Allergic Asthma Therapeutics Market Drivers
2.3.3 Allergic Asthma Therapeutics Market Challenges
2.3.4 Allergic Asthma Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allergic Asthma Therapeutics Players by Revenue
3.1.1 Global Top Allergic Asthma Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Allergic Asthma Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Allergic Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Allergic Asthma Therapeutics Revenue
3.4 Global Allergic Asthma Therapeutics Market Concentration Ratio
3.4.1 Global Allergic Asthma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allergic Asthma Therapeutics Revenue in 2024
3.5 Global Key Players of Allergic Asthma Therapeutics Head office and Area Served
3.6 Global Key Players of Allergic Asthma Therapeutics, Product and Application
3.7 Global Key Players of Allergic Asthma Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Allergic Asthma Therapeutics Breakdown Data by Type
4.1 Global Allergic Asthma Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Allergic Asthma Therapeutics Forecasted Market Size by Type (2026-2031)
5 Allergic Asthma Therapeutics Breakdown Data by Application
5.1 Global Allergic Asthma Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Allergic Asthma Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Allergic Asthma Therapeutics Market Size (2020-2031)
6.2 North America Allergic Asthma Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Allergic Asthma Therapeutics Market Size by Country (2020-2025)
6.4 North America Allergic Asthma Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Allergic Asthma Therapeutics Market Size (2020-2031)
7.2 Europe Allergic Asthma Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Allergic Asthma Therapeutics Market Size by Country (2020-2025)
7.4 Europe Allergic Asthma Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Allergic Asthma Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Allergic Asthma Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Allergic Asthma Therapeutics Market Size (2020-2031)
9.2 Latin America Allergic Asthma Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Allergic Asthma Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Allergic Asthma Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allergic Asthma Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Allergic Asthma Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aslan Pharmaceuticals Pte. Ltd.
11.1.1 Aslan Pharmaceuticals Pte. Ltd. Company Details
11.1.2 Aslan Pharmaceuticals Pte. Ltd. Business Overview
11.1.3 Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Introduction
11.1.4 Aslan Pharmaceuticals Pte. Ltd. Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.1.5 Aslan Pharmaceuticals Pte. Ltd. Recent Development
11.2 Axikin Pharmaceuticals, Inc.
11.2.1 Axikin Pharmaceuticals, Inc. Company Details
11.2.2 Axikin Pharmaceuticals, Inc. Business Overview
11.2.3 Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Introduction
11.2.4 Axikin Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.2.5 Axikin Pharmaceuticals, Inc. Recent Development
11.3 Baxalta Incorporated
11.3.1 Baxalta Incorporated Company Details
11.3.2 Baxalta Incorporated Business Overview
11.3.3 Baxalta Incorporated Allergic Asthma Therapeutics Introduction
11.3.4 Baxalta Incorporated Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.3.5 Baxalta Incorporated Recent Development
11.4 Chiesi Farmaceutici SpA
11.4.1 Chiesi Farmaceutici SpA Company Details
11.4.2 Chiesi Farmaceutici SpA Business Overview
11.4.3 Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Introduction
11.4.4 Chiesi Farmaceutici SpA Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.4.5 Chiesi Farmaceutici SpA Recent Development
11.5 Circassia Pharmaceuticals Plc
11.5.1 Circassia Pharmaceuticals Plc Company Details
11.5.2 Circassia Pharmaceuticals Plc Business Overview
11.5.3 Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Introduction
11.5.4 Circassia Pharmaceuticals Plc Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.5.5 Circassia Pharmaceuticals Plc Recent Development
11.6 CSL Limited
11.6.1 CSL Limited Company Details
11.6.2 CSL Limited Business Overview
11.6.3 CSL Limited Allergic Asthma Therapeutics Introduction
11.6.4 CSL Limited Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.6.5 CSL Limited Recent Development
11.7 Fountain Biopharma Inc.
11.7.1 Fountain Biopharma Inc. Company Details
11.7.2 Fountain Biopharma Inc. Business Overview
11.7.3 Fountain Biopharma Inc. Allergic Asthma Therapeutics Introduction
11.7.4 Fountain Biopharma Inc. Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.7.5 Fountain Biopharma Inc. Recent Development
11.8 GlaxoSmithKline Plc
11.8.1 GlaxoSmithKline Plc Company Details
11.8.2 GlaxoSmithKline Plc Business Overview
11.8.3 GlaxoSmithKline Plc Allergic Asthma Therapeutics Introduction
11.8.4 GlaxoSmithKline Plc Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.8.5 GlaxoSmithKline Plc Recent Development
11.9 Hydra Biosciences, Inc.
11.9.1 Hydra Biosciences, Inc. Company Details
11.9.2 Hydra Biosciences, Inc. Business Overview
11.9.3 Hydra Biosciences, Inc. Allergic Asthma Therapeutics Introduction
11.9.4 Hydra Biosciences, Inc. Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.9.5 Hydra Biosciences, Inc. Recent Development
11.10 Infinity Pharmaceuticals, Inc.
11.10.1 Infinity Pharmaceuticals, Inc. Company Details
11.10.2 Infinity Pharmaceuticals, Inc. Business Overview
11.10.3 Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Introduction
11.10.4 Infinity Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.10.5 Infinity Pharmaceuticals, Inc. Recent Development
11.11 Kineta, Inc.
11.11.1 Kineta, Inc. Company Details
11.11.2 Kineta, Inc. Business Overview
11.11.3 Kineta, Inc. Allergic Asthma Therapeutics Introduction
11.11.4 Kineta, Inc. Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.11.5 Kineta, Inc. Recent Development
11.12 Mabtech Limited
11.12.1 Mabtech Limited Company Details
11.12.2 Mabtech Limited Business Overview
11.12.3 Mabtech Limited Allergic Asthma Therapeutics Introduction
11.12.4 Mabtech Limited Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.12.5 Mabtech Limited Recent Development
11.13 Marinomed Biotechnologie GmbH
11.13.1 Marinomed Biotechnologie GmbH Company Details
11.13.2 Marinomed Biotechnologie GmbH Business Overview
11.13.3 Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Introduction
11.13.4 Marinomed Biotechnologie GmbH Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.13.5 Marinomed Biotechnologie GmbH Recent Development
11.14 Mycenax Biotech Inc.
11.14.1 Mycenax Biotech Inc. Company Details
11.14.2 Mycenax Biotech Inc. Business Overview
11.14.3 Mycenax Biotech Inc. Allergic Asthma Therapeutics Introduction
11.14.4 Mycenax Biotech Inc. Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.14.5 Mycenax Biotech Inc. Recent Development
11.15 NeoPharm Co., Ltd.
11.15.1 NeoPharm Co., Ltd. Company Details
11.15.2 NeoPharm Co., Ltd. Business Overview
11.15.3 NeoPharm Co., Ltd. Allergic Asthma Therapeutics Introduction
11.15.4 NeoPharm Co., Ltd. Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.15.5 NeoPharm Co., Ltd. Recent Development
11.16 Oxagen Limited
11.16.1 Oxagen Limited Company Details
11.16.2 Oxagen Limited Business Overview
11.16.3 Oxagen Limited Allergic Asthma Therapeutics Introduction
11.16.4 Oxagen Limited Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.16.5 Oxagen Limited Recent Development
11.17 Panacea Biotec Limited
11.17.1 Panacea Biotec Limited Company Details
11.17.2 Panacea Biotec Limited Business Overview
11.17.3 Panacea Biotec Limited Allergic Asthma Therapeutics Introduction
11.17.4 Panacea Biotec Limited Revenue in Allergic Asthma Therapeutics Business (2020-2025)
11.17.5 Panacea Biotec Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Axikin Pharmaceuticals, Inc.
Baxalta Incorporated
Chiesi Farmaceutici SpA
Circassia Pharmaceuticals Plc
CSL Limited
Fountain Biopharma Inc
GlaxoSmithKline PLC
Hydra Biosciences Inc
Infinity Pharmaceuticals, Inc.
Kineta
Mabtech
Marinomed Biotechnologie GmbH
Mycenax Biotech Inc
Neopharm
Oxagen Limited
Panacea Biotec Limited
Aslan Pharmaceuticals Pte Ltd
List of Tables
 Table 1. Global Allergic Asthma Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of ASM-8
 Table 3. Key Players of AXP-1275
 Table 4. Key Players of Beta-escin
 Table 5. Key Players of CHF-6001
 Table 6. Key Players of CSL-311
 Table 7. Key Players of Dalazatide
 Table 8. Key Players of Others
 Table 9. Global Allergic Asthma Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Allergic Asthma Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Allergic Asthma Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Allergic Asthma Therapeutics Market Share by Region (2020-2025)
 Table 13. Global Allergic Asthma Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Allergic Asthma Therapeutics Market Share by Region (2026-2031)
 Table 15. Allergic Asthma Therapeutics Market Trends
 Table 16. Allergic Asthma Therapeutics Market Drivers
 Table 17. Allergic Asthma Therapeutics Market Challenges
 Table 18. Allergic Asthma Therapeutics Market Restraints
 Table 19. Global Allergic Asthma Therapeutics Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Allergic Asthma Therapeutics Market Share by Players (2020-2025)
 Table 21. Global Top Allergic Asthma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergic Asthma Therapeutics as of 2024)
 Table 22. Ranking of Global Top Allergic Asthma Therapeutics Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Allergic Asthma Therapeutics Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Allergic Asthma Therapeutics, Headquarters and Area Served
 Table 25. Global Key Players of Allergic Asthma Therapeutics, Product and Application
 Table 26. Global Key Players of Allergic Asthma Therapeutics, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Allergic Asthma Therapeutics Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Allergic Asthma Therapeutics Revenue Market Share by Type (2020-2025)
 Table 30. Global Allergic Asthma Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Allergic Asthma Therapeutics Revenue Market Share by Type (2026-2031)
 Table 32. Global Allergic Asthma Therapeutics Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Allergic Asthma Therapeutics Revenue Market Share by Application (2020-2025)
 Table 34. Global Allergic Asthma Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Allergic Asthma Therapeutics Revenue Market Share by Application (2026-2031)
 Table 36. North America Allergic Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Allergic Asthma Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Allergic Asthma Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Allergic Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Allergic Asthma Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Allergic Asthma Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Allergic Asthma Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Allergic Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Allergic Asthma Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Allergic Asthma Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Allergic Asthma Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Aslan Pharmaceuticals Pte. Ltd. Company Details
 Table 52. Aslan Pharmaceuticals Pte. Ltd. Business Overview
 Table 53. Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Product
 Table 54. Aslan Pharmaceuticals Pte. Ltd. Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 55. Aslan Pharmaceuticals Pte. Ltd. Recent Development
 Table 56. Axikin Pharmaceuticals, Inc. Company Details
 Table 57. Axikin Pharmaceuticals, Inc. Business Overview
 Table 58. Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Product
 Table 59. Axikin Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 60. Axikin Pharmaceuticals, Inc. Recent Development
 Table 61. Baxalta Incorporated Company Details
 Table 62. Baxalta Incorporated Business Overview
 Table 63. Baxalta Incorporated Allergic Asthma Therapeutics Product
 Table 64. Baxalta Incorporated Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 65. Baxalta Incorporated Recent Development
 Table 66. Chiesi Farmaceutici SpA Company Details
 Table 67. Chiesi Farmaceutici SpA Business Overview
 Table 68. Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Product
 Table 69. Chiesi Farmaceutici SpA Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 70. Chiesi Farmaceutici SpA Recent Development
 Table 71. Circassia Pharmaceuticals Plc Company Details
 Table 72. Circassia Pharmaceuticals Plc Business Overview
 Table 73. Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Product
 Table 74. Circassia Pharmaceuticals Plc Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 75. Circassia Pharmaceuticals Plc Recent Development
 Table 76. CSL Limited Company Details
 Table 77. CSL Limited Business Overview
 Table 78. CSL Limited Allergic Asthma Therapeutics Product
 Table 79. CSL Limited Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 80. CSL Limited Recent Development
 Table 81. Fountain Biopharma Inc. Company Details
 Table 82. Fountain Biopharma Inc. Business Overview
 Table 83. Fountain Biopharma Inc. Allergic Asthma Therapeutics Product
 Table 84. Fountain Biopharma Inc. Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 85. Fountain Biopharma Inc. Recent Development
 Table 86. GlaxoSmithKline Plc Company Details
 Table 87. GlaxoSmithKline Plc Business Overview
 Table 88. GlaxoSmithKline Plc Allergic Asthma Therapeutics Product
 Table 89. GlaxoSmithKline Plc Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 90. GlaxoSmithKline Plc Recent Development
 Table 91. Hydra Biosciences, Inc. Company Details
 Table 92. Hydra Biosciences, Inc. Business Overview
 Table 93. Hydra Biosciences, Inc. Allergic Asthma Therapeutics Product
 Table 94. Hydra Biosciences, Inc. Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 95. Hydra Biosciences, Inc. Recent Development
 Table 96. Infinity Pharmaceuticals, Inc. Company Details
 Table 97. Infinity Pharmaceuticals, Inc. Business Overview
 Table 98. Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Product
 Table 99. Infinity Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 100. Infinity Pharmaceuticals, Inc. Recent Development
 Table 101. Kineta, Inc. Company Details
 Table 102. Kineta, Inc. Business Overview
 Table 103. Kineta, Inc. Allergic Asthma Therapeutics Product
 Table 104. Kineta, Inc. Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 105. Kineta, Inc. Recent Development
 Table 106. Mabtech Limited Company Details
 Table 107. Mabtech Limited Business Overview
 Table 108. Mabtech Limited Allergic Asthma Therapeutics Product
 Table 109. Mabtech Limited Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 110. Mabtech Limited Recent Development
 Table 111. Marinomed Biotechnologie GmbH Company Details
 Table 112. Marinomed Biotechnologie GmbH Business Overview
 Table 113. Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Product
 Table 114. Marinomed Biotechnologie GmbH Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 115. Marinomed Biotechnologie GmbH Recent Development
 Table 116. Mycenax Biotech Inc. Company Details
 Table 117. Mycenax Biotech Inc. Business Overview
 Table 118. Mycenax Biotech Inc. Allergic Asthma Therapeutics Product
 Table 119. Mycenax Biotech Inc. Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 120. Mycenax Biotech Inc. Recent Development
 Table 121. NeoPharm Co., Ltd. Company Details
 Table 122. NeoPharm Co., Ltd. Business Overview
 Table 123. NeoPharm Co., Ltd. Allergic Asthma Therapeutics Product
 Table 124. NeoPharm Co., Ltd. Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 125. NeoPharm Co., Ltd. Recent Development
 Table 126. Oxagen Limited Company Details
 Table 127. Oxagen Limited Business Overview
 Table 128. Oxagen Limited Allergic Asthma Therapeutics Product
 Table 129. Oxagen Limited Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 130. Oxagen Limited Recent Development
 Table 131. Panacea Biotec Limited Company Details
 Table 132. Panacea Biotec Limited Business Overview
 Table 133. Panacea Biotec Limited Allergic Asthma Therapeutics Product
 Table 134. Panacea Biotec Limited Revenue in Allergic Asthma Therapeutics Business (2020-2025) & (US$ Million)
 Table 135. Panacea Biotec Limited Recent Development
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources
 Table 139. Authors List of This Report


List of Figures
 Figure 1. Allergic Asthma Therapeutics Picture
 Figure 2. Global Allergic Asthma Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Allergic Asthma Therapeutics Market Share by Type: 2024 VS 2031
 Figure 4. ASM-8 Features
 Figure 5. AXP-1275 Features
 Figure 6. Beta-escin Features
 Figure 7. CHF-6001 Features
 Figure 8. CSL-311 Features
 Figure 9. Dalazatide Features
 Figure 10. Others Features
 Figure 11. Global Allergic Asthma Therapeutics Market Size by Application (2020-2031) & (US$ Million)
 Figure 12. Global Allergic Asthma Therapeutics Market Share by Application: 2024 VS 2031
 Figure 13. Clinic Case Studies
 Figure 14. Research Center Case Studies
 Figure 15. Hospital Case Studies
 Figure 16. Others Case Studies
 Figure 17. Allergic Asthma Therapeutics Report Years Considered
 Figure 18. Global Allergic Asthma Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Allergic Asthma Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Allergic Asthma Therapeutics Market Share by Region: 2024 VS 2031
 Figure 21. Global Allergic Asthma Therapeutics Market Share by Players in 2024
 Figure 22. Global Top Allergic Asthma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergic Asthma Therapeutics as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Allergic Asthma Therapeutics Revenue in 2024
 Figure 24. North America Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Allergic Asthma Therapeutics Market Share by Country (2020-2031)
 Figure 26. United States Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Allergic Asthma Therapeutics Market Share by Country (2020-2031)
 Figure 30. Germany Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Allergic Asthma Therapeutics Market Share by Region (2020-2031)
 Figure 38. China Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Allergic Asthma Therapeutics Market Share by Country (2020-2031)
 Figure 46. Mexico Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Allergic Asthma Therapeutics Market Share by Country (2020-2031)
 Figure 50. Turkey Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Allergic Asthma Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Aslan Pharmaceuticals Pte. Ltd. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 54. Axikin Pharmaceuticals, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 55. Baxalta Incorporated Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 56. Chiesi Farmaceutici SpA Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 57. Circassia Pharmaceuticals Plc Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 58. CSL Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 59. Fountain Biopharma Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 60. GlaxoSmithKline Plc Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 61. Hydra Biosciences, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 62. Infinity Pharmaceuticals, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 63. Kineta, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 64. Mabtech Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 65. Marinomed Biotechnologie GmbH Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 66. Mycenax Biotech Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 67. NeoPharm Co., Ltd. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 68. Oxagen Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 69. Panacea Biotec Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Asthma Therapeutics Market Research Report 2025
Global Asthma Medication Market Research Report 2025
Global Asthma Therapeutic Drug Market Research Report 2024
Global Asthma Clinical Therapeutic Drug Market Research Report 2025
Global Allergy Rhinitis Drug Market Research Report 2025
Global Allergy Rhinitis Drugs Market Research Report 2024
OTC Allergy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inhaled Anti Infectives Market Research Report 2025
Global Food Allergy Diagnostics and Therapeutics Market Research Report 2024
Oral Anti allergic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Allergy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Long Term Asthma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immune System Allergy Treatment Market Research Report 2025
Severe Asthma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Allergy Treatment Market Research Report 2025
Global Still s Disease Treatment Market Research Report 2025
Global Combination Therapy Drug Market Research Report 2025
Global Aerosol Bronchodilator Market Research Report 2025
Global Pesticide Residue and Allergen Testing Market Research Report 2025
Global Medicines for Alzheimer Disease Treatment Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions